Form type | Sec Links | Description | Filing date | Reporting date |
---|---|---|---|---|
SC 13D/A | Report | SC 13D/A | Oct 10, 2024 | |
SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / ONKURE THERAPEUTICS, INC. -- SCHEDULE 13D/A | Oct 8, 2024 | |
SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMA -- SCHEDULE 13D/A(#1) | May 8, 2024 | |
SC 13D | Report | Dec 26, 2023 | ||
SC 13D/A | Report | SC 13D/A | Dec 15, 2023 | |
SC 13D/A | Report | SC 13D/A | May 30, 2023 | |
SC 13D/A | Report | SC 13D/A | May 15, 2023 | |
SC 13D/A | Report | SC 13D/A | May 9, 2023 | |
SC 13D/A | Report | SC 13D/A | Sep 30, 2022 | |
SC 13D/A | Report | SC 13D/A | Aug 11, 2022 | |
SC 13D/A | Report | SC 13D/A | Jan 27, 2022 | |
SC 13D | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D | Apr 23, 2021 | |
SC 13D | Report | SC 13D | Apr 20, 2021 | |
SC 13D | Report | SC 13D | Apr 19, 2021 | |
SC 13D | Report | SC 13D | Apr 14, 2021 |